Therapeutic peptide characterization with LC-HRMS

Therapeutic peptides are rapidly transforming the pharmaceutical landscape, offering targeted, potent, and safer treatment options for a wide range of diseases—from metabolic disorders to cancer. As their complexity grows, so does the need for sophisticated analytical tools to ensure their efficacy, safety, and regulatory compliance.

In this webinar, we’ll explore how High-Resolution Mass Spectrometry (HRMS) and advanced characterization techniques are enabling deeper insights into peptide structures, impurities, and unknowns—paving the way for innovation in drug development.

Who Should Attend?

• Analytical scientists, pharmaceutical researchers, regulatory professionals, and anyone involved in peptide drug development

Agenda:

• Therapeutic peptides: what and why?
• Semaglutide characterization
• Impurity analysis
• Unknown analysis

Presenter: Himanshu Malani, PhD (Application Support Scientist, SCIEX)